Pharmacokinetics of theophylline in preterm neonates during the first month of life

Saudi Medical Journal

Volumn 25, Issue 4, 2004, Pages 459-465

  Islam, Samira I ^a   Ali, Ahmed S ^c   Sheikh, Amal A ^b   Fida, Nadia M ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c Assiut University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOPHYLLINE; CEFOTAXIME; CIMETIDINE; GENTAMICIN; PHENOBARBITAL; THEOPHYLLINE; VANCOMYCIN;

APNEA; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PEDIATRIC HOSPITAL; PREMATURITY; RECURRENT DISEASE; SAUDI ARABIA; STEADY STATE;

AMINOPHYLLINE; APNEA; BRONCHODILATOR AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; THEOPHYLLINE;

EID: 2342623950     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Aggarwal R, Singhal A, Deorari AK, Paul VK. Apnea in the newborn. Indian J Pediatr 2001; 68: 959-962.
2. Henderson Smart DJ. Recurrent Apnea. In: Yu VYH, editor. Bailliere's Clinical Pediatrics: Pulmonary problems in the perinatal period and their sequelae. Volume 3. London (UK): Bailliere Tindall; 1995. p. 203-222.
3. Miller MJ, Martin RJ. Apnea of prematurity. Clinics in Perinatology 1992; 19: 789-808.
4. Harris MC, Baumgart S, Rooklin AR. Successful extubation of infants with respiratory distress syndrome using aminophylline. J Pediatr 1983; 103: 303-305.
5. Peliowski A, Finer NN. A blinded, randomized placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea prematurity. J Pediatr 1990; 116: 648-653.
6. Capers CC, Ward ES, Murphy JE, Job ML, Land PA. Use of theophylline in neonates as an aid to ventilator weaning. Drug Monit 1992; 14: 471-474.
7. van Lunteren E, Vafaie H, Miller MJ. Effect of theophylline on pharyngeal dilator and diaphragm muscle contractile properties. Respiration 1996; 63: 88-93.
8. Comer AM, Perry CM, Figgitt DP. Caffeine citrate: A review of its use in apnea of prematurity. Pediatr Drugs 2001; 3: 61-79.
9. El-Sayed YM, Islam SI, High performance liquid chromatography analysis of theophylline in serum and its use in Therapeutic drug monitoring. Journal Clinical Pharmacy Therapeutics 1989; 14: 35-43.
10. El-Sayed YM, Islam SI. Comparison of fluorescence polarization immunoassay and HPLC for the determination of theophylline in serum. J Clin Pharm Ther 1989; 14: 127-134.
11. Aranda JV, Gronsin D, Sasynick BL. Pharmacologic consideration in the therapy of neonatal apnea. Pedia Clinical North Am 1981; 28: 113-133.
12. Kraus DM, Fischer JH, Reitz SJ, Kecskes SA, Yeh TF, McCulloch KM, et al. Alterations in theophylline metabolism during the first year of life. Clin Pharmacol Therap 1993; 54: 351-359.
13. Brazier JL, Renaud H, Ribon B, Salle BL. Plasma Xanthine levels in low birth weight infants treated or not treated with theophylline. Arch Dis Child 1979; 54: 194-199.
14. Baird-Lambert J, Doyle PE, Thomas D, Jager-Roman E, Cvejic M, Buchanan N. Theophylline metabolism in preterm neonates during the first week of life. Dev Pharmacol Ther 1984; 7: 239-244.
15. Heimann G, Murgescu J, Bergt U. Influence of food intake on bioavailability of theophylline in premature infants. Eur J Clin Pharmacol 1982; 22: 171-173.
16. Gilman JT, Gal P, Levine RS, Hersh CB, Erkan NV. Factors influencing theophylline disposition in 179 newborns. Ther Drug Monit 1986; 8: 4-10.
17. Dothey CI, Tserng KY, Kaw S, King KC. Maturational changes of theophylline pharmacokinetics in preterm infant. Clin Pharmacol Ther 1989; 45: 461-468.
18. Hilligoss DM, Jusko WJ, Koup JR, Giacoia G. Factors affecting theophylline pharmacokinetics in premature infants with apnea. Dev Pharmacol Ther 1980; 1: 6-15.
19. Neese AL, Soyka LF. Development of radioimmunoassay lot theophylline: application to studies in premature infants. Clin Pharmacolo Ther 1977; 21: 633-641.
20. Latini R, Assaeil B, Bonati M. Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn. Eur J Clin Pharmacol 1978; 12: 203-207.
21. Jones RA, Baillie E. Dosage schedule for intravenous aminophylline in apnea of of prematurity based on pharmacokinetic studies. Arch Dis Child 1979; 54: 190-193.
22. Giacoia G, Jusko WJ, Menke J, Koup JR. Theophylline pharmacokinetics in premature infants with apnea. J Pediatr 1976; 89: 829-832.
23. Riechert M, Lipowsky G, Stockl H, Stiegler H. Pharmacokinetics of theophylline and caffeine in premature infants with apnea. Monatsschr Kinderheilkd 1981; 129: 697-702.
24. Gal P, Boer HR, Toback J, Wells TJ, Erkan NV. Effects of asphyxia on theophylline clearance in newborns. South Med J 1982; 75: 836-838.
25. Lonnerholm G, Lindstrom B, Paalzow L, Sedin G. Plasma theophylline and caffeine plasma clearance of theophylline during theophylline treatment in the first year of life. Eur J Clin Pharmacol 1983; 24: 371-374.
26. Stile IL, Zolfaghari S, Hiatt IM, Hegyi T. Pharmacokinetics of theophylline in premature infants on the first day of life. Clin Ther 1986; 8: 336-341.
27. Micali G, Bhatt RH, Disrafeno G, Caltabiano L, Cook B, Fisher JH et al. Evaluation of transdermal theophylline pharmacokinetics in neonates. Pharmacotherapy 1993; 13: 386-390.
28. Ahn HW, Shin WG, Park KJ, Suh OK, Choi JH. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea. Res Commun Mol Pathol Pharmacol 1999; 105: 105-113.
29. Moore ES, Faix RG, Banagale RC, Grasela TH. The population pharmacokinetics of Theophylline in neonates and young infants. J Pharmacokinet Biopharm 1989; 12: 65-69.
30. Karlsson MO, Thomson AH, McGovern EM, Chow P, Evans TJ, Kelman AW. Population pharmacokinetics of rectal theophylline in neonates. Ther Drug Monit 1991; 13: 195-200.
31. Lee TC, Charles BG, Steer PA, Flenady VJ, Grant TC. Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnea. Br J Clin Pharmacol 1996; 41: 191-200.
32. du Preez MJ, Botha JH, McFadyen ML, Holford NH. The pharmacokinetics of theophylline in premature neonates during after birth. Ther Drug Monit 1999; 21: 598-603.
33. Grygiel JJ, Birkett DJ. Effect of age on patterns of theophylline metabolism. Clin Pharmacol Ther 1980; 28: 456-462.
34. Lelo A, Birkett DJ, Robson RA, Miners JO. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxenthine, theobromine, and theophylline in man. Br J Clin 1986; 22: 177-182.
35. Sarkar MA, Hunt C, Guzelian PS, Karnes HT. Characterization of human liver cytochrome P-450 involved in theophylline metabolism. Drug Metab Disp 1992; 20: 31-37.
36. Tserng K, Takieddine FN, King KC. Development aspects of theophylline metabolism in premature infants. Clin Pharmacol Ther 1983; 4: 522-528.
37. Kandrotas RJ, Cranfield TL, Gal P, Ransom JL, Weaver RL. Effect of Phenobarbital administration on theophylline clearance in premature neonates. Ther Drug Monit 1990; 12: 39-43.
38. Griffin JP, D'arcy PF, Speirs CJ. Drug interactions. A clinical prospective and analysis of current developments. London (UK): Editors Applied Therapeutic Inc; 1988. p. 231-233.